otsuka, daiichi

custom search

REVERSED
Tech Center 1600 Biotechnology and Organic Chemistry
1616 Ex Parte Doney 11495993 - (D) LEBOVITZ 103 International Specialty Products SHIN, MONICA A

1625 Ex Parte Littich et al 14681324 - (D) SCHEINER Concurring NEW 103 Elevance Renewable Sciences, Inc. SOLOLA, TAOFIQ A

Moreover, the United States Court of Appeals for the Federal Circuit has explained when evaluating the prima facie obviousness of a new chemical compound in view of similar prior art compounds, one must first determine "whether a chemist of ordinary skill would have selected the asserted prior art compounds as lead compounds, or starting points, for further development efforts." Otsuka Pharm. Co., Ltd. v. Sandoz, Inc., 678 F.3d 1280, 1291 (Fed. Cir. 2012). 

The court has further advised: 

While the lead compound analysis must, in keeping with KSR, not rigidly focus on the selection of a single, best lead compound ... , the analysis still requires the challenger to demonstrate ... that one of ordinary skill in the art would have had a reason to select a proposed lead compound or compounds over other compounds in the prior art. 

Daiichi Sankyo Co. v. Matrix Labs., Ltd., 619 F.3d 1346, 1354 (Fed. Cir. 2010) ( citation omitted, emphasis added). 

In addition, the court has explained that "proving a reason to select a compound as a lead compound depends on more than just structural similarity, but also knowledge in the art of the functional properties and limitations of the prior art compounds." Id.; see also Otsuka, 678 F.3d at 1292 ("Absent a reason or motivation based on such prior art evidence [ of the proposed lead compound's pertinent properties], mere structural similarity between a prior art compound and the claimed compound does not inform the lead compound selection.") ( emphasis added). 

1631 Ex Parte ROELLE et al 14693999 - (D) GRIMES 101 Drinker Biddle & Reath LLP (WM) BORIN, MICHAEL L

1637 Ex Parte WHITMAN et al 14270785 - (D) NEW Concurring KATZ 102/103 Parker Highlander PLLC CHUNDURU, SURYAPRABHA

Tech Center 1700 Chemical & Materials Engineering
1732 Ex Parte Imanishi et al 14436242 - (D) GAUDETTE 103 FLYNN THIEL, P.C. QIAN, YUN

1765 Ex Parte Pan et al 14126500 - (D) COLAIANNI 102 Drinker Biddle & Reath LLP (WM) TRUONG, DUC

1778 Ex Parte Han et al 12703423 - (D) COLAIANNI 103 KURTZ, BENJAMIN M KURTZ, BENJAMIN M

Tech Center 2100 Computer Architecture and Software
2131 Ex Parte Ghai et al 12424284 - (D) SHIANG 112(1)/103 IBM CORP. (WIP) c/o WALDER INTELLECTUAL PROPERTY LAW, P.C. LOONAN, ERIC T

Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2834 Ex Parte Jayasoma et al 13384841 - (D) DEJMEK 103 JONES ROBB, PLLC (w/Nony & Partners) TRUONG, THOMAS

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3647 Ex Parte Suciu et al 14874560 - (D) MARTIN 103 CARLSON, GASKEY & OLDS/PRATT & WHITNEY FRAZIER, BRADY W

3678 Ex Parte Houston 14519163 - (D) MARTIN 103 COATS & BENNETT, PLLC FIORELLO, BENJAMIN F

3693 Ex Parte Sahota et al 13828504 - (D) DIXON 101 KILPATRICK TOWNSEND & STOCKTONLLP/VISA CHAKRAVART!, ARUNAVA

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3763 Ex Parte Gruenberg et al 13768303 - (D) CRAWFORD 102/103 BROOKS KUSHMAN P.C./FG1L OSWALD, KIRSTIN U

3791 Ex Parte Gal et al 13540656 - (D) HILL 103 41.50 112(1)/112(2) Leason Ellis LLP TOTH, KAREN E

3793 Ex Parte Wodlinger et al 14127136 - (D) GRIMES 101/103 TAROLLI, SUNDHEIM, COVELL & TUMMINO L.L.P. MEHL, PATRICK M

AFFIRMED-IN-PART
Tech Center 1600 Biotechnology and Organic Chemistry
1611 Ex Parte Blatt et al 10995208 - (D) SCHNEIDER 103 103 Abel Schillinger, LLP PURDY, KYLE A

1651 Ex Parte Schenk et al 10522320 - (D) GRIMES 103 103 CR MILES P.C. GOUGH, TIFFANY MAUREEN

1653 Ex Parte Damcevski et al 14467942 - (D) FLAX 102/103 OTDP COOPER & DUNHAM, LLP CHONG, STEPHEN M

Tech Center 1700 Chemical & Materials Engineering
1711 Ex Parte Lim et al 14420771 - (D) BEST 103 103 PHILIPS INTELLECTUAL PROPERTY & STANDARDS AYALEW, TINSAE B

Tech Center 2400 Networking, Multiplexing, Cable, and Security
2442 Ex Parte Meisels et al 13096880 - (D) RAEVSKY 112(1)/103 103 MERCHANT & GOULD (MICROSOFT) BLAIR, DOUGLAS B

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3675 Ex Parte DOW et al 14724179 - (D) HOFFMANN 102/103 112(2) CANTOR COLBURN LLP MERLINO, ALYSON MARIE

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3761 Ex Parte Matiash et al 14535575 - (D) MARTIN 103 103 CORRIGAN LAW OFFICE WARD, THOMAS JOHN

AFFIRMED
Tech Center 1600 Biotechnology and Organic Chemistry
1611 Ex Parte LANGGUTH et al 14607861 - (D) LEBOVITZ 103 MILLEN, WHITE, ZELANO & BRANIGAN, P.C. ORWIG, KEVIN S

1611 Ex Parte HOUGH et al 14603128 - (D) LAVIER 103 JONES DAY for Celgene Corporation BAEK, BONG-SOOK

1611 Ex Parte MORALES 15103791 - (D) WISZ 112(1) 103 Medtronic Vascular - APV Division GHALI, ISIS AD

1625 Ex Parte GRANT et al 14810617 - (D) VALEK 103 Johnson Matthey Inc. AULAKH, CHARANJIT

1637 Ex Parte Lidgard et al 14539841 - (D) FREDMAN 103 EPA - Bozicevic Field & Francis LLP Bozicevic, Field & Francis PRIEST, AARON A

1663 Ex Parte Wu et al 13243446 - (D) MILLS 112(1)/101 COOPER & DUNHAM, LLP BAUM, STUART F

Tech Center 1700 Chemical & Materials Engineering
1744 Ex Parte Feichtinger et al 14351866 - (D) DENNETT 102/103/OTDP KILPATRICK TOWNSEND & STOCKTONLLP SHAFI, LEITH S

1785 Ex Parte Verschuuren et al 14443181 - (D) HOUSEL 103 PHILIPS INTELLECTUAL PROPERTY & STANDARDS SHEWAREGED, BETELHEM

1787 Ex Parte Bordet et al 12089467 - (D) SNAY 103 OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L.P. HUANG, CHENG YUAN

1789 Ex Parte Taguchi et al 14647720 - (D) COLAIANNI 103 GREENBLUM & BERNSTEIN, P.L.C. JUSKA, CHERYL ANN

1792 Ex Parte McCurdy et al 12920834 - (D) SQUIRE 102/103 112(2) Alltech, Inc. LEFF, STEVEN N

1793 Ex Parte Stenvik 14575686 - (D) COLAIANNI 103 DIEDERIKS & WHITELAW, PLC COX, AMBER M

1797 Ex Parte Haechler et al 14271550 - (D) GARRIS 103 ROCHE DIAGNOSTICS OPERATIONS INC. HIXSON, CHRISTOPHER

Tech Center 2100 Computer Architecture and Software
2124 Ex Parte Eshghi 13873587 - (D) DIXON 103 101 ENTIT SOFTWARE LLC TRAN, MAI T

2125 Ex Parte Gammel et al 13409369 - (D) PINKERTON 103 MURPHY, BILAK & HOMILLER/INFINEON TECHNOLOGIES GIROUX, GEORGE

2169 Ex Parte Hadar et al 13223413 - (D) COURTENAY 112(1)/103 Gilliam IP PLLC (Broadcom) KIM, PAUL

2199 Ex Parte Guan et al 14086433 - (D) McNEILL 103 Cantor Colburn LLP - IBM Endicott AQUINO, WYNUEL S

Tech Center 2400 Networking, Multiplexing, Cable, and Security
2446 Ex Parte VLACHOGIANNIS et al 14528526 - (D) CYGAN 103 Shook, Hardy & Bacon L.L.P. (Splunk Inc.) TOKUTA, SHEAN S

2457 Ex Parte Strumwasser et al 13831375 - (D) CHUNG 103 112(2)/101 WESTERMAN, HATTORI, DANIELS & ADRIAN, LLP LI, MICHAEL J

2459 Ex Parte Li et al 13645823 - (D) KHAN 103 101 Setter Roche LLP RASHID, ISHRAT

2489 Ex Parte DeNoble et al 13414393 - (D) BENNETT 103 ZIOLKOWSKI PATENT SOLUTIONS GROUP, SC (ZPS) KIR, ALBERT

2494 Ex Parte Roth et al 15409120 - (D) BARRY 103/OTDP Hogan Lovells US LLP - Amazon GERGISO, TECHANE

Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2875 Ex Parte GHANNAM et al 14537941 - (D) HOUSEL 103 BROOKS KUSHMAN P.C./FGTL GRAMLING, SEAN P

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3623 Ex Parte Babylon et al 13482635 - (D) SAADAT 101/103 IBM (END-KLS) c/o Kennedy Lenart Spraggins LLP ANDERSON, FOLASHADE

3624 Ex Parte Gruber et al 13251118 - (D) FISCHETTI 103 101 DENTONS US LLP - Apple ZIMMERMAN, JEFFREY P

3624 Ex Parte Ascano 14244477 - (D) BEAMER 101/103 THOMAS I HORSTEMEYER, LLP ZIMMERMAN, JEFFREY P

3628 Ex Parte Luwang et al 14076195 - (D) EVANS 101 SCHWEGMAN LUNDBERG & WOESSNER/SAP ERB, NATHAN

3629 Ex Parte CHAUBAL et al 12886242 - (D) HUGHES 101 BOND SCHOENECK & KING, PLLC PRATT, EHRINLARMONT

3646 Ex Parte Hol et al 12850370 - (D) WOOD 101 112(1)/112(2)/103 MILLER, MATTHIAS & HULL LLP NGUYEN, CHUONG P

3682 Ex Parte Wigder et al 12692090 - (D) POTHIER 101 Maldjian Law Group LLC HAMILTON, MATTHEW L

3688 Ex Parte NIEJADLIK et al 12795586 - (D) COURTENAY 101 MatterLight IP MACASIANO, MARILYN G

3692 Ex Parte Bok et al 13668566 - (D) CHUNG 103 112(1)/101 Prince Lobel Tye LLP GAW, MARK H

3692 Ex Parte Tofte et al 13778717 - (D) MOHANTY 101 Slayden Grubert Beard PLLC HAMILTON, SARA CHANDLER

3693 Ex Parte MARINCOLA et al 13722197 - (D) SHAH 112(1)/101 101/103 MORRISON & FOERSTER LLP BARTLEY, KENNETH

3694 Ex Parte Brewer 13271278 - (D) BAUMEISTER 101 Garlick & Markison (IH) ANDERSON, SCOTT C

3695 Ex Parte Pechenik et al 12537552 - (D) FISCHETTI 112(2)/103 101 IP GROUP OF DLA PIPER LLP (US) POLLOCK, GREGORY A

3695 Ex Parte Salmon et al 13842969 - (D) FISCHETTI 101 LOEB & LOEB, LLP LIU, CHIA-YI

3697 Ex Parte Rajagopal et al 13655307 - (D) DEJMEK 101 FBFK/Intuit TRAN, HAI

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3715 Ex Parte Ginsberg et al 14922825 - (D) FITZPATRICK 101 CANTOR FITZGERALD, L.P. COBURN, CORBETT B

3772 Ex Parte Hurson 13572476 - (D) BAYAT 112(1) 103 KNOBBE MARTENS OLSON & BEAR LLP SAUNDERS, MATTHEW P

3783 Ex Parte Harding 14326072 - (D) STAICOVICI 103 Kirton McConkie Craig Metcalf LEGETTE-THOMPSON, TIFFANY

3792 Ex Parte Carbunaru et al 12952845 - (D) MELVIN 103 SCHWEGMAN LUNDBERG & WOESSNER/BSC LEVICKY, WILLIAM J

3793 Ex Parte Hynynen 13170367 - (D) STAICOVICI 103 DOWELL & DOWELL, P.C. NGUYEN, HIEN NGOC

3794 Ex Parte Budzelaar et al 13884696 - (D) WOODS 103 PHILIPS INTELLECTUAL PROPERTY & STANDARDS FOWLER, DANIEL WAYNE

REEXAMINATION

REVERSED
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2442 Ex parte CHRISTOPHER J. ROURK Ex Parte 9213357 et al 90013959 - (D) HOFF 103 Lee Sullivan Shea & Smith LLP ENGLAND, DAVID E original SURVILLO, OLEG

AFFIRMED
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2826 KILOPASS TECHNOLOGY, INC., Requester, v. SIDENSE CORPORATION, Patent Owner. Ex Parte 7402855 et al 10/553,873 95001359 - (D) SIU 103 Synopsys/Fenwick GAGLIARDI, ALBERT J original SEFER, AHMED N

otsuka

custom search

REVERSED
Tech Center 2100 Computer Architecture and Software
2128 Ex Parte Conrad 13123531 - (D) MOORE 102/103 Iselin Law PLLC (HAL) BROCK, ROBERT S

2171 Ex Parte Gilley et al 13187140 - (D) FRAHM 103 Van Court & Aldridge LLP Apple Inc. NUNEZ, JORDANY

Tech Center 2400 Networking, Multiplexing, Cable, and Security
2468 Ex Parte Saru et al 12744687 - (D) DEJMEK 103 Myertons, Hood, Kivlin, Kowert & G (Apple) KASSIM, KHALED M

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3628 Ex Parte Ramadei et al 11512527 - (D) MOHANTY 103 PITNEY BOWES INC. CLARK, DAVID J

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3742 Ex Parte Sigler et al 13777345 - (D) KERINS 103 REISING ETHINGTON P.C. General Motors Corporation MATHEW, HEMANT MATHAI

AFFIRMED-IN-PART
Tech Center 1600 Biotechnology and Organic Chemistry
1616 Ex Parte Schmaus et al 10558364 - (D) TOWNSEND 103 103 Dilworth & Barrese, LLP PRYOR, ALTON NATHANIEL

“[P]ertinent properties guide the analysis [for modifying a lead compound], for it is the possession of promising useful properties in a lead compound that motivates a chemist to make structurally similar compounds.”  Otsuka Pharm. Co., Ltd. v. Sandoz, Inc., 678 F.3d 1280, 1292–93 (Fed. Cir. 2012) (internal citation omitted).

AFFIRMED
Tech Center 2100 Computer Architecture and Software
2194 Ex Parte Elrod 11897707 - (D) MOORE 103 LOWENSTEIN SANDLER LLP DORAIS, CRAIG C

Tech Center 2600 Communications
2689 Ex Parte Johnson et al 11529445 - (D) FENICK 103 HAVERSTOCK & OWENS LLP JIANG, YONG HANG

otsuka, takeda, altana

custom search

REVERSED
Tech Center 2100 Computer Architecture and Software
2116 Ex Parte Kuo et al 12060356 - (D) SHAW 103 McClure, Qualey & Rodack, LLP KINSEY, BRANDON MICHAEL

Tech Center 2400 Networking, Multiplexing, Cable, and Security
2412 Ex Parte LAULAINEN et al 12254361 - (D) HOMERE 102/103 YOUNG & THOMPSON Winston Products LLC PHUNKULH, BOB A

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3677 Ex Parte Breeden et al 12644484 - (D) ASTORINO 102/103 Cooper Legal Group LLC MERCADO, LOUIS A

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3715 Ex Parte Wilkins 11734325 - (D) GREENHUT 103 FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER LLP PAGE, EVAN RANDALL

AFFIRMED-IN-PART
Tech Center 1600 Biotechnology and Organic Chemistry
1624 Ex Parte Xiong et al 12444098 - (D) POLLOCK 112(1)/102/103/improper Markush group 112(1) FISH & RICHARDSON P.C. Arena Pharmaceuticals, Inc. WILSON, JAMES O

The Federal Circuit provides a two-prong analysis to determine whether a new chemical compound is prima facie obvious over particular prior art.  The fact finder first determines whether a chemist of ordinary skill would have selected the asserted prior art compounds as lead compounds, or starting points, for further development efforts.  Otsuka Pharm. Co. Ltd. v. Sandoz Inc., 678 F.3d 1280, 1291 (Fed. Cir. 2012). The Court defines a lead compound as "a compound in the prior art that would be most promising to modify in order to improve upon its ... activity and obtain a compound with better activity," Takeda Chem. Indus., Ltd. v. Alphapharm Pty. Ltd., 492 F.3d 1350, 1357 (Fed. Cir 2007), or "a natural choice for further development efforts." Altana Pharma AG v. Teva Pharm. USA, Inc., 566 F.3d 999, 1008 (Fed. Cir 2009).  The second step involves determining "whether the prior art would have supplied one of ordinary skill in the art with a reason or motivation to modify a lead compound to make the claimed compound with a  reasonable expectation of success." Otsuka, 678 F.3d at 1292 (citing Takeda, 492 F.3d at 1357)

AFFIRMED
Tech Center 1700 Chemical & Materials Engineering
1725 Ex Parte MacKinnon et al 12683120 - (D) DERRICK 103 Brooks Kushman P.C. GM Global Technologies Operations Inc. CULLEN, SEAN P

1783 Ex Parte Butterworth 12056695 - (D) Per Curiam 112(2) 103 WOMBLE CARLYLE SANDRIDGE & RICE, LLP JOHNSON, NANCY ROSENBERG

Tech Center 2100 Computer Architecture and Software
2142 Ex Parte BAE et al 12017403 - (D) WIEKER 102/103 SUGHRUE MION, PLLC KEATON, SHERROD L

2183 Ex Parte Cavin 11964604 - (D) ULLAGADDI 103 Mnemoglyphics, LLC c/o CPA Global VICARY, KEITH E

Tech Center 2400 Networking, Multiplexing, Cable, and Security
2424 Ex Parte Zhou et al 12176221 - (D) NEW 102 Intellectual Property Investment Law Group / SISA BROWN, RUEBEN M

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3627 Ex Parte Bruecken 11987745 - (D) FETTING 103 LEE & HAYES, PLLC SHEIKH, ASFAND M

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3744 Ex Parte Jager 11792450 - (D) MAYBERRY 103 SHELL OIL COMPANY RAYMOND, KEITH MICHAEL

3753 Ex Parte Cheney et al 12685823 - (D) GREENHUT 103 Van Cott, Bagley, Cornwall & McCarthy CAHILL, JESSICA MARIE

REEXAMINATION

AFFIRMED
Tech Center 2100 Computer Architecture and Software
2111 CHIMEI INNOLUX DISPLAY CORPORATION, Requester, v. MONDIS TECHNOLOGY LTD., Patent Owner. Ex Parte 7475180 et al 10/160,022 95000480 - (D) SIU 102/103 DECHERT LLP For THIRD PARTY REQUESTER: COOLEY LLP ATTN: PATENT GROUP LEE, CHRISTOPHER E original PHAN, RAYMOND NGAN

otsuka, takeda, altana

custom search

REVERSED 
Tech Center 1600 Biotechnology and Organic Chemistry
1624 Ex Parte Goldstein et al 11899758 - (D) POLLOCK 103 Hoffmann-La Roche Inc. C/O Gibbons P.C. RAO, DEEPAK R

The Federal Circuit provides a two-prong analysis to determine whether a new chemical compound is prima facie obvious over particular prior art. The fact finder first determines whether a chemist of ordinary skill would have selected the asserted prior art compounds as lead compounds, or starting points, for further development efforts. (Otsuka Pharm. Co. v. Sandoz Inc., 678 F.3d 1280, 1291 (Fed. Cir. 2012). The Court defines a lead compound as “a compound in the prior art that would be most promising to modify in order to improve upon its ... activity and obtain a compound with better activity,” (Takeda Chem. Indus., Ltd. v. Alphapharm Pty., Ltd., 492 F.3d 1350, 1357 (Fed. Cir. 2007), or “a natural choice for further development efforts.” Altana Pharma AG v. Teva Pharm. USA, Inc., 566 F.3d 999, 1008 (Fed. Cir. 2009). The second step involves determining “whether the prior art would have supplied one of ordinary skill in the art with a reason or motivation to modify a lead compound to make the claimed compound with a reasonable expectation of success.” Otsuka, 678 F.3d at 1292 (citing Takeda, 492 F.3d at 1357).

Tech Center 2100 Computer Architecture and Software
2166 Ex Parte Muras 12105774 - (D) WORMEESTER 103 WOOD, HERRON & EVANS, L.L.P. (IBM) LIN, SHEW FEN

Tech Center 2600 Communications
2672 Ex Parte Umekage et al 10572421 - (D) ADAMS 103 EDWARDS WILDMAN PALMER LLP PACHOL, NICHOLAS C

Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2842 Ex Parte Kim et al 11198596 - (D) KRATZ 103 BLAKELY SOKOLOFF TAYLOR & ZAFMAN CHENG, DIANA

AFFIRMED 
Tech Center 1700 Chemical & Materials Engineering
1765 Ex Parte Weikard et al 11217725 - (D) GRIMES 103 obviousness-type double patenting NOVAK DRUCE CONNOLLY BOVE + QUIGG LLP SERGENT, RABON A

Tech Center 2400 Networking, Multiplexing, Cable, and Security
2474 Ex Parte Chaudhry et al 12144120 - (D) HUME 112(2)/102(e) WALL & TONG, LLP/ALCATEL-LUCENT USA INC. ELLIOTT IV, BENJAMIN H

Tech Center 2600 Communications
2695 Ex Parte Wallash et al 11701091 - (D) DANG 103 HGST C/O WAGNER BLECHER LLP WATKO, JULIE ANNE

Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2883 Ex Parte Helvenstein 12077186 - (D) GARRIS 103 SOFER & HAROUN LLP. TAVLYKAEV, ROBERT FUATOVICH

REEXAMINATION

AFFIRMED 
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3711 Ex parte AINSWORTH GAME TECHNOLOGY LIMITED Appellant, Patent Owner Ex Parte 6,544,120 et al 09/862,182 90012063 - (D) BAHR 112(1)/102/103 112(2) MARSHALL, GERSTEIN & BORUN LLP THIRD PARTY REQUESTER: MCANDREWS HELD & MALLOY, LTD ENGLISH, PETER C original LAYNO, BENJAMIN